KIR3DL1-HLA-Bw4 combination and IL28B polymorphism predict response to Peg-IFN and ribavirin with and without telaprevir in chronic hepatitis C
Author:
Publisher
Elsevier BV
Subject
General Medicine,Immunology,Immunology and Allergy
Reference28 articles.
1. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus;Kiyosawa;Hepatology,1990
2. Epidemiology of hepatocellular carcinoma in Japan;Umemura;J Gastroenterol,2009
3. Telaprevir with peginterferon and ribavirin for treatment-naive patients chronically infected with HCV of genotype 1 in Japan;Kumada;J Hepatol,2012
4. Efficacy and safety of telaprevir, a new protease inhibitor, for difficult-to-treat patients with genotype 1 chronic hepatitis C;Hayashi;J Viral Hepat,2012
5. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance;Ge;Nature,2009
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Influence of HLA-C environment on the spontaneous clearance of hepatitis C in European HIV–HCV co-infected individuals;Clinical and Experimental Immunology;2021-02-02
2. Killer cell immunoglobulin-like receptors (KIR) and human leukocyte antigen-C (HLA-C) allorecognition patterns in women with endometriosis;Scientific Reports;2020-03-17
3. Decreased interferon‐γ production by NK cells from KIR haplotype B carriers in hepatitis C virus infection;Liver International;2019-06-26
4. Association between KIR-HLA combination and ulcerative colitis and Crohn’s disease in a Japanese population;PLOS ONE;2018-04-12
5. Higher expression of inhibitory CD158b and CD158e NK cell receptor and age predicts treatment response in children with chronic hepatitis C;Medical Microbiology and Immunology;2017-11-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3